Bacterial Infection: Clinical Trials

63 trials for Bacterial Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 5 unknown, 3 terminated, 1 not yet recruiting. 13 Not applicable, 12 Phase 1, 10 Phase 4, 7 Phase 2, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable13Completed 13
Phase 112Completed 10, Terminated 1, Withdrawn 1
Phase 410Completed 8, Recruiting 1, Terminated 1
Phase 27Completed 6, Withdrawn 1
Phase 36Completed 4, Terminated 1, Unknown 1
Early Phase 11Unknown 1

Follow Bacterial Infection: new trials by email Literature Review of Bacterial Infection trials Research Report on Bacterial Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Culture of Perfusion Fluid on Donor-derived Infection Management and Outcome in Liver and Kidney Transplant
Liver Transplant Infection, Kidney Transplant Infection
Not yet recruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna14002026-09-012026-06-16
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Rifaximin 200 mg Tablet, Oral Rehydration Therapy (ORT) - Diarrhea, Gastroenteritis
Phase 4RecruitingBausch Health Americas, Inc.542026-02-112026-08-13
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
Iohexol - Bacterial Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1612025-02-122026-07-31
EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS
Meropenem Infusion - Sepsis, Bacterial Infection
Phase 4CompletedPakistan Navy Station Shifa Hospital1502024-04-012025-08-14
Safety of Intravenous Apramycin in Adults
Apramycin (EBL-1003) - Bacterial Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)162023-06-162025-03-06
Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)
Ertapenem, Placebo, WCK 6777 - Bacterial Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)542023-04-192025-01-20
Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
QingFei Granule, Cefuroxime - Upper Respiratory Tract Infection, Bacterial Infection
Early Phase 1UnknownZhong Wang602020-10-172022-11-15
A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam
AZACTAM, Ceftazidime-Avibactam - Bacterial Infection
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)482019-07-092022-06-07
Intravenous Fosfomycin Pharmacokinetics Study
Fosfomycin disodium - Bacterial Infection, Multiple-drug Resistance
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)392019-06-272023-10-23
Minocycline Pharmacokinetics (ACUMIN)
Minocycline - Bacterial Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)582018-03-282020-12-03
Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department
systematic calculation of qSOFA - Bacterial Infection, Intensive Care
Not applicableCompletedCentre Hospitalier Régional d'Orléans7802017-10-122018-08-01
Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections
Bacterial Infection
CompletedNantes University Hospital3352016-09-222026-06-24
Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)
Tigecycline - Bacterial Infection, Critically Ill
UnknownZhujiang Hospital202016-08-012016-10-13
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
MBN-101, Placebo - Bacterial Infection
Phase 2CompletedMicrobion Corporation292016-05-242021-09-30
Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer
Chlorhexidine, NaCl 0.9 % - Bacterial Infection
Phase 3CompletedRennes University Hospital802016-05-232018-12-20
Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis
Biological sampling grinding, Biological sampling with standard procedures - Bacterial Infection
Not applicableCompletedCentre Hospitalier Universitaire de Nīmes1222016-05-182026-02-02
Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis
Seraph 100 Filter - Bacteremia, Bacterial Infection
Not applicableCompletedExThera Medical Corporation152016-02-012019-08-12
Elimination of Antibiotics During Citrate-anticoagulated Continuous-veno-venous-haemodialysis
Acute Kidney Injury, Bacterial Infection
UnknownHeinrich-Heine University, Duesseldorf302015-09-012020-05-11
Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods
Educational Intervention - Bacterial Infection, Clostridium Difficile
Not applicableCompletedCase Comprehensive Cancer Center382015-01-272018-01-31
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
Larval Debridement Therapy, Bedside Sharp Debridement - Lower Extremity or Diabetic Foot Ulcers, Bacterial Infection
Not applicableCompletedNorth Florida Foundation for Research and Education452015-01-012020-04-07

Showing 20 of 63. Sign in to see all of them.

Narrower conditions

Bacterial Infections (63)  ·  Infections (7)  ·  Sepsis (6)  ·  Diarrhea (5)  ·  Gastroenteritis (4)  ·  Escherichia coli Infections (3)  ·  Mycoses (3)  ·  Neutropenia (3)  ·  Abscess (2)  ·  Bacteremia (2)  ·  Cellulitis (2)  ·  Communicable Diseases (2)  ·  Fever (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)

Broader conditions

Bacterial Infections and Mycoses (63)  ·  Infections (56)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Pathologic Processes (17)  ·  Inflammation (10)  ·  Systemic Inflammatory Response Syndrome (8)  ·  Signs and Symptoms (7)  ·  Digestive System Diseases (5)  ·  Disease Attributes (5)  ·  Signs and Symptoms, Digestive (5)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Gastrointestinal Diseases (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Urogenital Diseases (4)

Interventions

Aztreonam (2)  ·  Chlorhexidine (2)  ·  Daptomycin (2)  ·  Probiotics (2)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (2)  ·  Amikacin (1)  ·  Azithromycin (1)  ·  Cefadroxil (1)  ·  Cefazolin (1)  ·  Cefotaxime (1)  ·  Ceftaroline (1)  ·  Ceftriaxone (1)  ·  Cefuroxime (1)  ·  Ciprofloxacin (1)  ·  Clindamycin (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (8)  ·  NIZO Food Research (3)  ·  Children's Oncology Group (2)  ·  Johns Hopkins Bloomberg School of Public Health (2)  ·  Nantes University Hospital (2)  ·  Rennes University Hospital (2)  ·  Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2)  ·  AM-Pharma (1)  ·  Aga Khan University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bausch Health Americas, Inc. (1)  ·  Brahms AG (1)  ·  Butler Hospital (1)  ·  Case Comprehensive Cancer Center (1)  ·  Cellceutix Corporation (1)

Countries

United States (26)  ·  France (10)  ·  Canada (4)  ·  Germany (4)  ·  Netherlands (4)  ·  China (2)  ·  Italy (2)  ·  Norway (2)  ·  Pakistan (2)  ·  Australia (1)  ·  Austria (1)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Hungary (1)

Top investigators

Alan Bruce Montgomery (1)  ·  Anita KM Zaidi, MBBS, SM (1)  ·  Arthur Ouwehand, PhD (1)  ·  Atreya Dash, MD (1)  ·  Brett Baker, MSc, DC (1)  ·  Brett T Phillips, MD (1)  ·  Bruno Laviolle, MD, PhD (1)  ·  Danielle M Zerr (1)  ·  David Edwards, Pharm.D. (1)  ·  David Nicolau, PharmD (1)  ·  Detlef Kindgen-Milles, Prof. (1)  ·  Duc T Bui, MD (1)  ·  Elias Tessema, M.D. (1)

Results publications

PMID 19671016, PMID 20352087, PMID 21965811, PMID 22330925, PMID 23930950, PMID 25369827, PMID 26701793, PMID 26942345, PMID 27106640, PMID 27597981, PMID 29374589, PMID 29891609, PMID 31103379, PMID 31190298, PMID 31318840, PMID 32716292, PMID 32830383, PMID 33813580, PMID 34398099, PMID 35715801, PMID 37260312, PMID 39772650, PMID 41594285, PMID 42809435

NIH funding

U10CA095861 (2), 2UM1AI104681-08 (1), 5UM1AI104681-09 (1), 5UM1AI104681-12 (1), P30CA043703 (1), R01CA163394 (1), R01HD044004 (1), UG1CA189955 (1)